Skip to main content
SRTS
NASDAQ Industrial Applications And Services

Sensus Healthcare Reports Significant 2025 Loss, 34% Revenue Decline, and Credit Covenant Default

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$4.355
Mkt Cap
$71.531M
52W Low
$3.03
52W High
$5.92
Market data snapshot near publication time

summarizeSummary

Sensus Healthcare reported a 34% revenue decrease and a $7.7 million net loss for 2025, leading to a default on a credit facility profitability covenant, alongside ongoing customer concentration and a DOJ investigation.


check_boxKey Events

  • Significant Financial Decline

    Revenue decreased by 34% to $27.5 million in 2025 from $41.8 million in 2024. The company swung to a net loss of $7.7 million in 2025, compared to a net income of $6.6 million in 2024.

  • Credit Facility Covenant Default

    As of December 31, 2025, Sensus Healthcare was in default under its $15 million revolving credit facility for failing to maintain the required minimum profitability covenant.

  • High Customer Concentration

    One U.S. customer accounted for 52% of the company's revenue in 2025 and 65% of its accounts receivable, indicating significant reliance on a single client.

  • Ongoing DOJ Investigation

    The company is subject to a Civil Investigative Demand from the Department of Justice, initiated in August 2019, concerning Medicare billing practices by a physician using its SRT-100 product.


auto_awesomeAnalysis

Sensus Healthcare's annual report reveals a substantial deterioration in financial performance for fiscal year 2025, marked by a significant revenue decline and a swing to a net loss. The company's revenue decreased by 34% to $27.5 million, and it reported a net loss of $7.7 million, a sharp reversal from a $6.6 million net income in 2024. This downturn led to a default on a minimum profitability covenant under its $15 million revolving credit facility, raising concerns about its financial health despite management's assertion of sufficient liquidity for the next 12 months. The company also continues to face high customer concentration, with one U.S. customer accounting for 52% of its 2025 revenue. While new CPT codes effective January 2026 are anticipated to boost demand and new service offerings were launched, the immediate financial results and covenant breach present significant challenges.

At the time of this filing, SRTS was trading at $4.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $71.5M. The 52-week trading range was $3.03 to $5.92. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SRTS - Latest Insights

SRTS
Mar 27, 2026, 8:05 AM EDT
Source: Reuters
Importance Score:
8
SRTS
Mar 04, 2026, 12:15 PM EST
Filing Type: 10-K
Importance Score:
9
SRTS
Feb 12, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
SRTS
Jan 09, 2026, 7:25 PM EST
Filing Type: 8-K
Importance Score:
7